Table 3.
Upstream Regulator | Protein Name | Activation z-Score | p-Value of Overlap | Differentially Expressed Downstream Target Proteins 1 |
---|---|---|---|---|
ANGPT2 | Angiopoeitin 2 | 3.08 | 7.41 × 10−9 | CALR, CRYAB, HSP90AA1, HSPA2, HSPA5, P4HB, PDIA3, PDIA6, POSTN, RPS6 |
EGFR | Epidermal growth factor | 2.62 | 1.38 × 10−3 | CRYAB, HNRNPH1, HSP90B1, HSPA5, POSTN, PPIA, VIM |
XBP1 | X box binding protein 1 | 2.41 | 8.79 × 10−3 | CALR, HSP90B1, HSPA5, PDIA3, PDIA4, PDIA6 |
TGFB1 | Transforming growth factor beta 1 | 2.21 | 1.95 × 10−6 | AK1, ANXA2, CAPNS1, COL7A1, CTSB, DES, EEF1A1, FLNA, FSCN1, GATD3A/GATD3B, HNT1, HNRNPH1, HSP90A1, HAPA5, IARS, IGHM, LDHA, PGK1, PLS3, POSTN, RAB1A, RACK1, RHOA, VIM, YWHAE |
NFE2L2 | Nuclear factor (erythroid-derived 2)-like 2 | 2.18 | 4.3 × 10−9 | ARF1, CBR1, DSTN, HSP90AA1, HSP90B1, ME1, PDIA3, PDIA4, PDIA6, PGD, RACK1, RAN, RPL18, RPLPO, TPI1 |
RICTOR | Regulatory-associated protein Independent of mTOR complex 2 | −3.61 | 2.06 × 10−9 | PSMC2, RPL11, RPL18, RPL4, RPL6, RPLP0, RPS11, RPS2, RPS24, RPS3 |
PPARGC1A | Peroxisome proliferator activator receptor gamma-coactivator 1 α | −2.35 | 1.92 × 10−4 | AK1, C3, CS, GOT2, LDHA, ME1, PGAM1 |
AHR | Aryl hydrocarbon receptor | −2.22 | 2.02 × 10−3 | ABCB6, CBR1, GOT1, HSP90AA1, HSPA5, IGHM, VIM |
ARNT | Aryl hydrocarbon receptor nuclear translocator | −2.20 | 3.35 × 10−6 | ALDOC, GAPDH, IGHM, LDHA, PGK1, TPI1, VIM |
ESRRG (NR3B3) | Estrogen related receptor gamma | −2.17 | 1.89 × 10−6 | ALDOC, GAPDH, LDHA, PKM, TPI1 |
1 Target molecules in plain red type were up-regulated (p < 0.05, >1.3-fold difference) in WB myopathy compared to normal tissue. Target molecules in bold green and underlined type were down-regulated (p < 0.05, <−1.3-fold difference) in WB myopathy compared to normal tissue. ANGPT2: Angiopoeitin 2; EGFR: epidermal growth factor; XBP1: X box binding protein; TGFB1: transforming growth factor beta 1; NFE2L2: nuclear factor (erythroid-derived 2)-like 2.